Positron Corporation (POSC) Research

Positron Corporation is a healthcare firm specializing in nuclear medicine, with a core emphasis on cardiac Positron Emission Tomography (PET) imaging services throughout the United States. The company empowers healthcare providers by offering its proprietary Attrius PET scanner, comprehensive clinical and technical support, and flexible financing solutions. These integrated offerings enable medical professionals to precisely diagnose heart conditions, enhance patient health outcomes, and deliver medical care with greater cost-efficiency. Positron Corporation was founded in 1983 and operates from its headquarters in Niagara Falls, New York.

Market snapshot

Symbol
POSC
Price
$1.82
Day change
+3.44%
Market cap
$26.0M
P/E ratio
-5.72x
52-week range
1.27-2.74
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Aurora Spine Corporation (ASAPF)
  • Biotricity, Inc. (BTCY)
  • Elbit Imaging Ltd. (EMITF)
  • Finch Therapeutics Group, Inc. (FNCH)
  • Global Pharmatech, Inc. (GBLP)
  • Guided Therapeutics, Inc. (GTHP)
  • Oxford BioDynamics Plc (OXBOF)
  • PetVivo Holdings, Inc. (PETV)

Open Positron Corporation (POSC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.